Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

Friday’s trading has closed, but KERX is being traded in the after-hours session. After-Hours quote »
12.56
Delayed Data
As of 3:59pm ET
 -0.63 / -4.78%
Today’s Change
10.85
Today|||52-Week Range
18.48
-11.24%
Year-to-Date

Today’s Trading

Previous close13.19
Today’s open13.12
Day’s range12.40 - 13.15
Volume1,523,036
Average volume (3 months)1,663,322
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 03/06/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+26.42%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...-0.51-2.82%
ARIAARIAD Pharmaceutical...-0.17-2.06%
NXTMNxStage Medical Inc-0.44-2.56%
NKTRNektar Therapeutics-0.28-2.11%
Data as of 3:59pm ET, 03/06/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
President, Chief Operating Officer &
Executive VP
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account